MLN and Fabry disease: More notably, clinical trials have found that both the antidepressant mirtazapine [73] and certain phytochemicals [74,75] improve both depressive and gastrointestinal symptoms in patients with FD and that all these pharmacological agents are associated with significant increases in plasma motilin post-treatment.